We are working on a timeline to begin plasma collections under the ‘plasma pathway’ in 2025. We have also made a submission to the Therapeutic Goods Administration in 2024 for a gender-neutral or ‘Individual risk assessment’ approach for blood donation.
Join the list to stay up-to-date.